Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Autophagy Inducer, STF-62247 (CAS 315702-99-9)

5.0(1)
Write a reviewAsk a question

See product citations (3)

Application:
Autophagy Inducer, STF-62247 is selectively kills RCC cells that have lost VHL tumor suppressor activity
CAS Number:
315702-99-9
Purity:
≥95%
Molecular Weight:
267.35
Molecular Formula:
C15H13N3S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Autophagy Inducer, STF-62247 is a small molecule agonist that induces autophagy and selectively causes lethality in renal cell carcinoma (RCC) cells that have lost the von Hippel-Lindau (VHL) tumor suppressor activity (IC50 = 625 nM). It significantly reduces the growth rate of tumors formed from VHL-deficient cells in mice. STF-62247 induces cytotoxicity in VHL-positive RCC cells only at higher concentrations (IC50 = 16 μM). Selectively induces non-apoptotic cell death in VHL- (von Hippel-Lindau) deficient, but not VHL-expressing, renal carcinoma cells both in vitro (IC50 = 0.625 and 16 μM in RCC4 and RCC4/VHL killing, respectively) and in mice. Although STF-62247 induces autophagy regardless of cellular VHL-expression level, STF-62247 treatment is shown to result in more enhanced/acidified autolysomes formation in VHL-deficient cells, implicating an important role of VHL in maintaining normal vesicular trafficking between ER, TNG, and lysosomes.


Autophagy Inducer, STF-62247 (CAS 315702-99-9) References

  1. A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy.  |  Turcotte, S., et al. 2008. Cancer Cell. 14: 90-102. PMID: 18598947
  2. Targeted therapy for the loss of von Hippel-Lindau in renal cell carcinoma: a novel molecule that induces autophagic cell death.  |  Turcotte, S., et al. 2008. Autophagy. 4: 944-6. PMID: 18769110
  3. Targeting cancer cells by synthetic lethality: autophagy and VHL in cancer therapeutics.  |  Chan, DA. and Giaccia, AJ. 2008. Cell Cycle. 7: 2987-90. PMID: 18818511
  4. Quantitative proteomics to study a small molecule targeting the loss of von Hippel-Lindau in renal cell carcinomas.  |  Bouhamdani, N., et al. 2017. Int J Cancer. 141: 778-790. PMID: 28486780
  5. The small molecule STF-62247 induces apoptotic and autophagic cell death in leukemic cells.  |  Kozako, T., et al. 2018. Oncotarget. 9: 27645-27655. PMID: 29963226
  6. Loperamide, pimozide, and STF-62247 trigger autophagy-dependent cell death in glioblastoma cells.  |  Zielke, S., et al. 2018. Cell Death Dis. 9: 994. PMID: 30250198
  7. STF-62247 and pimozide induce autophagy and autophagic cell death in mouse embryonic fibroblasts.  |  Kinzler, MN., et al. 2020. Sci Rep. 10: 687. PMID: 31959760
  8. On-Demand Autophagy Cascade Amplification Nanoparticles Precisely Enhanced Oxaliplatin-Induced Cancer Immunotherapy.  |  Wang, X., et al. 2020. Adv Mater. 32: e2002160. PMID: 32596861
  9. Advances in autophagy as a target in the treatment of tumours.  |  Li, Y., et al. 2022. J Drug Target. 30: 166-187. PMID: 34319838
  10. Tailor-Made Autophagy Cascade Amplification Polymeric Nanoparticles for Enhanced Tumor Immunotherapy.  |  Long, X., et al. 2023. Small. e2207898. PMID: 36932938

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Autophagy Inducer, STF-62247, 10 mg

sc-203831
10 mg
$163.00

Autophagy Inducer, STF-62247, 25 mg

sc-203831A
25 mg
$347.00

Autophagy Inducer, STF-62247, 50 mg

sc-203831B
50 mg
$551.00